• N/A
    Market Cap
  • -92.92%
    1-Year Change
  • Medical Instruments & Supplies
    Industry

Key Performance

More
  • Earnings Score: N/A
  • Momentum Score: 39
  • True Yield: N/A
  • Financial Health Score: N/A
TradeSmith Loading

Latest Research & News

Cuprina Holdings Announces Completion of Reverse Stock Split and Requests a Hearing before the Nasdaq Hearings Panel to Maintain Listing

Cuprina Holdings completed a 1-for-8 reverse stock split on May 27, 2026, and requested a hearing before the Nasdaq Hearings Panel to appeal a delisting determination. The company failed to regain compliance with Nasdaq's minimum bid price requirement of $1.00 per share despite having until May 26, 2026 to do so. The hearing request will stay the suspension of trading pending the Panel's decision, and the company expects the share consolidation to bring its bid price into compliance.

05/29/2026, 12:55 PM • GlobeNewswire

Cuprina Holdings announces 1-for-8 Share Consolidation

Cuprina Holdings (Nasdaq: CUPR) announced a 1-for-8 share consolidation effective May 27, 2026, to regain compliance with Nasdaq Marketplace Rule 5550(a)(2) and maintain its listing on the Nasdaq Capital Market. The consolidation was approved by the board on April 21, 2026, and shareholders on May 14, 2026. The company's par value will increase from $0.001 to $0.008 per share, with no change to shareholders' percentage ownership except for fractional share adjustments.

05/22/2026, 10:50 AM • GlobeNewswire

CUPR Investors Have Opportunity to Join Cuprina Holdings (Cayman) Limited Fraud Investigation with the Schall Law Firm

The Schall Law Firm is investigating Cuprina Holdings (Cayman) Limited for potential securities law violations, including allegations of false or misleading statements and failure to disclose material information to investors. The firm is seeking shareholders who suffered losses to participate in the investigation.

04/26/2026, 8:23 PM • GlobeNewswire

Heads Up! The Bear Cave Nails These Pump-And-Dump Stocks: QMMM, Cuprina, Pitanium, Mint And More

The Bear Cave financial newsletter warns about potential pump-and-dump stock schemes targeting thinly traded China-based stocks, with several companies experiencing unusual trading volume and significant price movements.

09/10/2025, 1:24 PM • Benzinga

Are You Holding These 6 Potential Pump-And-Dump Stocks? The Bear Cave Sees These As The Next Targets

The Bear Cave investigative newsletter warns of widespread pump-and-dump scams targeting U.S.-listed Chinese stocks, coordinated via WhatsApp groups and using fake investment tactics to manipulate stock prices.

08/11/2025, 12:28 PM • Benzinga

Peers

Statistics

More
Day Range
$2.56
$2.87
$2.83
1-Year Range
$0.25
$9.40
$2.83
Latest Close$2.83
Change
+$0.15 (+5.30%)
Volume159,888
Shares Outstanding7.4M
P/E (TTM)-0.01
Diluted EPS (TTM)-$182.64

Information as of 06/03/2026

Company Profile

CUPRINA HOLDINGS (CAYMAN) LTD
https://www.cuprina.com.sg
N/A
Market Cap
-$4.3M
Net Income
Sector: Healthcare
Industry: Medical Instruments & Supplies
Blk 1090, Singapore, Singapore, 169201
65 8512 7275

Cuprina Holdings (Cayman) Limited, a biomedical and biotechnology company, focuses on the development and commercialization of products for the management of chronic wounds. The company manufactures and distributes a line of medical grade sterile blowfly larvae bio-dressing products used as a biological debridement tool for chronic wounds under the MEDIFLY brand name. It is also developing collagen dressings, including sponges, particles, and hydrogels using bullfrog collagen derived from the valorization of abattoir waste; and products using medical leeches for wound treatment. The company was founded in 2019 and is based in Singapore. Cuprina Holdings (Cayman) Limited operates as a subsidiary of Cuprina Holding Pte. Ltd.

Key Executives

  • Yong Qi Quek
  • Tat Jing Chan
  • Ronald Sherman

Current Ownership Distribution

  • Insiders14.1M (99.38%)
  • Institutions88,418 (0.62%)
  • Mutual Funds0 (0.00%)
  • Other0 (0.00%)